NSE: DRREDDY | BSE: 500124

Mid-range Performer

Download real time

1318.80 28.20 (2.19%)

29.29% Gain from 52W Low

1.8M NSE+BSE Volume

NSE 06 Jun, 2025 2:46 PM (IST)

110,055.6

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Partnership

Dr. Reddy's Lab and Alvotech to co-develop Keytruda biosimilar drug, with sales of $29.5 bn in 2024 See details

Dr. Reddy's Laboratories Ltd. News and Updates

Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 4
Author: KRChoksey

Keep track of all breaking news on Dr. Reddy's Laboratories Ltd. from all sources in a single place.

Is Dr. Reddy's Laboratories Ltd. worth buying?

509 Votes:

Buy 78.19%

Sell 12.18%

Hold 9.63%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Sell SEE REPORTS >

pdf